SMS Pharmaceuticals
SMSPHARMA · Pharma > Pharmaceuticals & Drugs · Chairman: Ramesh Babu · MD: Ramesh Babu · Listing date: Feb. 28, 2007 · Employees: 1080 · Hyderabad · http://www.smspharma.com

Stock Price vs Company Growth
1d
4.7%
1w
6.2%
1m
7.6%
3m
37.0%
6m
2.1%
1y
96.0%
5y
42.9%
10y
19.2%
all
11.7%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 232 4.7%
231
396
Company Overview

Sales
768 Cr
Growth: 25.6%
Profit after Tax
59.3 Cr
Growth: 4.2%
Small Cap
1,964 Cr
P/E: 33.0x
Industry P/E: 37.3x
Fundamentals

Sales (Cr) ₹ 768
Growth 25.6%
EBITDA 16.6%
P/S 2.6x
Dividend 0.2%
P/E 33.0x
Book Value ₹ 67
PEG Ratio 1.3x
ROE 11.0%
P/B 3.5x
Shareholding Pattern

Institutions
Venkata Subbaraju Penmatsa .
2.13 %
Vivek Mundra
1.23 %
Aniruddh Mundra
1.13 %
Madhusudan Murlidhar Kela
1.1 %
Iepf
0.07 %
Promoters
Ramesh Babu Potluri
18.37 %
Hima Bindu Potluri
17.47 %
Vamsi Krishna Potluri
15.74 %
Potluri Infra Projects Llp
8.68 %
Trilok Potluri
2.58 %
Others
Increase    Decrease    No change
Company Profile Detailed

SMS Pharmaceuticals Ltd. is a global player in API manufacturing having strong research and manufacturing team supported by state of art facilities. What started off as a single facility single product manufacturing company in 1990 grew to be a multi location group having product list spreading across an array of therapeutic segments. SMS is currently a listed company having ever appreciating international and domestic customer base.
Investors (45)